Transcode Therapeutics, Inc. ·
RNAZ 8-K 2026-09-28
Transcode Therapeutics, Inc. (RNAZ) 8-K dated 2026-09-28 — accession 0001104659-26-111170.
Transcode Therapeutics, Inc. (RNAZ) is a biotechnology company listed on NASDAQ.
Transcode Therapeutics, Inc. filed a 8-K on 2026-09-28. Accession 0001104659-26-111170.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for RNAZ is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The RNAZ SEC hub lists recent forms. The stock page is the research view.